Clinical Trial Update: French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat

View source ↗

Summary

A completed French prospective observational cohort study evaluating outcomes in Fabry disease patients treated with migalastat. Sponsor: Amicus Therapeutics Fr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• GALAFOLD (MIGALASTAT HYDROCHLORIDE)

Snippet

Sponsor: Amicus Therapeutics France SAS | Conditions: Fabry Disease | Status: COMPLETED